Shares Held (Direct Ownership) 20K
n/a 3M change
n/a 12M change
Total Value Held N/A

Mark C. McKenna Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 12 2024
BUY
Open market or private purchase
$988,600 $49.43 p/Share
20,000 Added 50.0%
20,000 Common Stock

Also insider at

RXDX
Prometheus Biosciences, Inc. Healthcare
AGLE
Aeglea BioTherapeutics, Inc. Healthcare
NAMS
NewAmsterdam Pharma Co N.V.
MCM

Mark C. Mc Kenna

Director
San Diego, CA

Track Institutional and Insider Activities on APGE

Follow Apogee Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APGE shares.

Notify only if

Insider Trading

Get notified when an Apogee Therapeutics, Inc. insider buys or sells APGE shares.

Notify only if

News

Receive news related to Apogee Therapeutics, Inc.

Track Activities on APGE